Frank Ondrey
Overview
Explore the profile of Frank Ondrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesnick A, Samuels T, Seabloom D, Wuertz B, Ojha A, Seelig D, et al.
Laryngoscope Investig Otolaryngol
. 2024 Feb;
9(1):e1219.
PMID: 38362183
Objectives: Approximately 25% of Americans suffer from laryngopharyngeal reflux (LPR), a disease for which no effective medical therapy exists. Pepsin is a predominant source of damage during LPR and a...
2.
Buryska S, Patel K, Wuertz B, Gaffney P, Ondrey F
Anticancer Res
. 2023 Nov;
43(12):5299-5310.
PMID: 38030164
Background/aim: Activin, a member of the TGF-β super family of cytokines, is involved in head and neck squamous cell carcinoma (HNSCC). This study examined the constituents of the activin axis...
3.
Buryska S, Arji S, Wuertz B, Ondrey F
Technol Cancer Res Treat
. 2023 Nov;
22:15330338231214250.
PMID: 37997353
Objective: Determine the interchangeability of various methods utilized for counting colonies in clonogenic assays. Methods: Clonogenic assays of 2 head and neck cancer cell lines were counted through 4 different...
4.
Archibald H, Kalland K, Kuehne A, Ondrey F, Roby B, Jakubowski L
Laryngoscope
. 2022 Sep;
133(7):1745-1748.
PMID: 36054728
Objective: There is a lack of data supporting cancer surveillance in pediatric Fanconi Anemia patients. We sought to describe the rates of upper aerodigestive lesions and malignancy in this population...
5.
Johnston N, Samuels T, Goetz C, Arnold L, Smith B, Seabloom D, et al.
Laryngoscope
. 2022 Jun;
133 Suppl 1:S1-S11.
PMID: 35678265
Objective: More than 20% of the US population suffers from laryngopharyngeal reflux. Although dietary/lifestyle modifications and alginates provide benefit to some, there is no gold standard medical therapy. Increasing evidence...
6.
Hall J, Rusten M, Abughazaleh R, Wuertz B, Souksavong V, Escher P, et al.
Head Neck
. 2020 Jun;
42(9):2542-2554.
PMID: 32519370
Background: Peroxisome proliferator-activated receptor-gamma (PPAR-γ) activators have anti-cancer effects. Our objective was to determine the effect of PPAR-γ ligands 15-deoxy-D -Prostaglandin J (15-PGJ ) and ciglitazone on proliferation, apoptosis, and...
7.
Rosas R, Buryska S, Silver R, Wuertz B, Ondrey F
Anticancer Res
. 2020 Jun;
40(6):3071-3080.
PMID: 32487601
Background/aim: Head and neck squamous cell carcinoma affects nearly 500,000 people annually. Augmenting PPARγ functional activation is linked with multiple anti-carcinogenic processes in aerodigestive cell lines and animal models. PPARγ/RXRα...
8.
Handley N, Eide J, Taylor R, Wuertz B, Gaffney P, Ondrey F
Laryngoscope
. 2016 Nov;
127(4):E124-E131.
PMID: 27896820
Objective: Peroxisome proliferator-activated receptor γ (PPARγ) agonists have been shown to have anti-proliferative, anti-angiogenic, and proapoptotic effects, leading to interest in their use as cancer therapeutics. Pioglitazone, a U.S. Food...
9.
Johnston N, Ondrey F, Rosen R, Hurley B, Gould J, Allen J, et al.
Ann N Y Acad Sci
. 2016 Jun;
1381(1):5-13.
PMID: 27310222
An ever-increasing number of adult and pediatric disorders have been shown to be influenced or caused by airway reflux. This has become a controversial and complicated aspect of medicine that...
10.
Cohen E, Karrison T, Kocherginsky M, Mueller J, Egan R, Huang C, et al.
J Clin Oncol
. 2014 Jul;
32(25):2735-43.
PMID: 25049329
Purpose: Induction chemotherapy (IC) before radiotherapy lowers distant failure (DF) rates in locally advanced squamous cell carcinoma of the head and neck (SCCHN). The goal of this phase III trial...